U.S. Price 2-4 times higher than rest of world. And U.S. Govt owns the patent!

Multiple Sclerosis drug Zinbryta's Pricing

Country	Single 150mg dose cost
Australia	$1,794.00
Canada	$1,906.00
Denmark	$2,654.00
Finland	$1,754.00
Germany	$2,556.00
Netherlands	$1,742.00
Norway	$2,670.00
Sweden	$1,737.00
Switzerland	$1,954.00
United Kingdom	$2,102.00
United States	$7,390.00

But wait...there is more…

Zinbryta is Priced Higher in the United States than Other High Income Countries While the United States funded the development of Zinbryta, and even holds the patent that protects the monopoly, Biogen and Abbvie are charging far more in the United States than in other high-income countries

Source: https://t.co/ebSVv1MkDf

Tags: Elijah Cummings, KEI, Zinbryta, Biogen, Abbvie